New Delhi – The World Health Organization (WHO) has issued a warning about four cough syrups made by ‘Maiden Pharmaceuticals’ in India in connection with the death of 66 children in the African country of Gambia. Cough syrups such as Promethazine Oral Solution, Cofexmaline Children’s Cough Syrup, Macoff Children’s Cough Syrup, and Magrip N Cough Syrup are not recommended.
The warning came amid suspicion that 66 children under the age of five in Gambia have died of kidney failure as a result of using these syrups. WHO chief Tedros Adhanom Ghebreyesus said WHO is investigating the matter with the company and regulators. WHO also warned that these drugs could be distributed outside the Gambia.
All four drugs have been found to contain excessive amounts of diethylene glycol and ethylene glycol. These can cause abdominal pain, vomiting, diarrhea, headache, and even kidney failure that can lead to death, the WHO said.
Summary in English: Indian cough syrup after the death of 66 children in Gambia: WHO
